Page last updated: 2024-09-04

diquafosol and uridine

diquafosol has been researched along with uridine in 5 studies

Compound Research Comparison

Studies
(diquafosol)
Trials
(diquafosol)
Recent Studies (post-2010)
(diquafosol)
Studies
(uridine)
Trials
(uridine)
Recent Studies (post-2010) (uridine)
126389212,749691,083

Protein Interaction Comparison

ProteinTaxonomydiquafosol (IC50)uridine (IC50)
Sodium/nucleoside cotransporter 1Homo sapiens (human)5.8
Solute carrier family 28 member 3Homo sapiens (human)5.4

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, WM; Boucher, RC; Boyer, J; Cowlen, M; Davis, CW; Dougherty, R; Jones, AC; Lang-Furr, M; Picher, M; Sabater, JR; Stutts, MJ; Yerxa, BR1
Evans, R; Kellerman, D; Mathews, D; Shaffer, C1
Amar, T; Caillaud, T; Douglass, JG; Edick, C; Elena, PP; Peterson, WM; Yerxa, BR1
Engels, J; Gorden, J; Kellerman, D; Rossi Mospan, A; Schaberg, A; Smiley, L1
Appy, L; Chardet, C; Peyrottes, S; Roy, B1

Reviews

3 review(s) available for diquafosol and uridine

ArticleYear
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease.
    Advanced drug delivery reviews, 2002, Dec-05, Volume: 54, Issue:11

    Topics: Administration, Inhalation; Animals; Clinical Trials as Topic; Cystic Fibrosis; Deoxycytosine Nucleotides; Epithelium; Humans; Mucociliary Clearance; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y2; Uracil Nucleotides; Uridine

2002
Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.
    Pulmonary pharmacology & therapeutics, 2008, Volume: 21, Issue:4

    Topics: Administration, Inhalation; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystic Fibrosis; Deoxycytosine Nucleotides; Female; Forced Expiratory Volume; Humans; Male; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2Y2; Uracil Nucleotides; Uridine

2008
Synthetic Strategies for Dinucleotides Synthesis.
    Molecules (Basel, Switzerland), 2019, Nov-27, Volume: 24, Issue:23

    Topics: Deoxycytosine Nucleotides; Dinucleoside Phosphates; Dry Eye Syndromes; Green Chemistry Technology; Humans; Ophthalmic Solutions; Phosphorylation; Polyphosphates; Purinergic P2Y Receptor Agonists; Receptors, Purinergic; Uracil Nucleotides; Uridine

2019

Other Studies

2 other study(ies) available for diquafosol and uridine

ArticleYear
Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Animals; Astrocytoma; Brain Neoplasms; Calcium; Chlorides; Cilia; Cystic Fibrosis; Deoxycytosine Nucleotides; Epithelial Cells; Humans; In Situ Hybridization; In Vitro Techniques; Indicators and Reagents; Macaca mulatta; Mucins; Mucociliary Clearance; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Reverse Transcriptase Polymerase Chain Reaction; Sheep; Tumor Cells, Cultured; Uracil Nucleotides; Uridine

2002
Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.
    Advances in experimental medicine and biology, 2002, Volume: 506, Issue:Pt A

    Topics: Animals; Deoxycytosine Nucleotides; Eye; Male; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Rabbits; Tears; Uracil Nucleotides; Uridine

2002